The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma

被引:53
作者
Han, F. -H. [1 ]
Li, H. -M. [1 ]
Zheng, D. -H. [1 ]
He, Y. -L. [1 ]
Zhan, W. -H. [1 ]
机构
[1] Sun Yat Sen Univ, Dept Gastrointestinal Surg, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China
来源
EJSO | 2010年 / 36卷 / 12期
关键词
Gastric carcinoma; VEGF-C; VEGFR-3; Lymphatic metastasis; Prognosis; LYMPH-NODE METASTASIS; BLOOD-VESSEL INVASION; CELL LUNG-CANCER; FACTOR-C; CLINICOPATHOLOGICAL PARAMETERS; PROGNOSTIC-SIGNIFICANCE; BREAST-CARCINOMA; LYMPHANGIOGENESIS; OVEREXPRESSION; ANGIOGENESIS;
D O I
10.1016/j.ejso.2010.09.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: We aimed to investigate the relationship among VEGF-C/VEGFR-3 expression, lymphatic metastasis and patient prognosis in gastric carcinoma. Material and methods: VEGF-C and VEGFR-3 expression in gastric carcinoma tissues obtained from 204 patients who underwent curative gastrectomy (105 cases presented with lymph node metastasis and 99 cases without metastasis) was examined immunohistochemically. There was no significant difference in the other clinicopathologic variables except for postoperative pathological tumor stage (pT) and TNM stage between the two groups. The results were statistically processed. Results: The results showed that VEGF-C was located mainly in the cytoplasm of tumor cells and VEGFR-3 was found predominantly in the endothelium of lymphatic vessels. VEGF-C and VEGFR-3 expression was more frequent in gastric carcinoma tissues than that in normal gastric tissues, 54.90% and 35.29% respectively, which revealed that the expression of VEGF-C and VEGFR-3 was significantly stronger in patients with lymph node metastasis than in those without metastasis. Patients who had positive staining for VEGF-C showed significantly less favorable survival rates compared with patients who had negative staining for VEGF-C. The survival rates of patients who had positive staining for VEGFR-3 also were significantly lower compared with patients who had negative staining for VEGFR-3. Patients who had positive staining for both VEGF-C and VEGFR-3 exhibited the most unfavorable prognosis. Multivariate analysis demonstrated that the expression of VEGF-C and VEGFR-3 was an independent prognostic determinant. In addition, faint to moderate VEGF-C expression was detected in normal gastric epithelial cells (18/204, 8.9%). Conclusions: VEGF-C and VEGFR-3 expression could serve as a prognostic biomarker in patients with gastric carcinoma. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1172 / 1179
页数:8
相关论文
共 35 条
  • [21] Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma
    Miyahara, Mayumi
    Tanuma, Jun-ichi
    Sugihara, Kazumasa
    Semba, Ichiro
    [J]. CANCER, 2007, 110 (06) : 1287 - 1294
  • [22] Lymphangiogenesis and cancer metastasis
    Mumprecht, Viviane
    Detmar, Michael
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (8A) : 1405 - 1416
  • [23] Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma
    Mylona, E.
    Alexandrou, P.
    Mpakali, A.
    Giannopoulou, I.
    Liapis, G.
    Markaki, S.
    Keramopoulos, A.
    Nakopoulou, L.
    [J]. EJSO, 2007, 33 (03): : 294 - 300
  • [24] Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up
    Nakamura, Y
    Yasuoka, H
    Tsujimoto, M
    Yang, QF
    Tsukiyama, A
    Imabun, S
    Nakahara, M
    Nakao, K
    Nakamura, M
    Mori, I
    Kakudo, K
    [J]. MODERN PATHOLOGY, 2003, 16 (04) : 309 - 314
  • [25] Nesi G, 2009, IN VIVO, V23, P337
  • [26] Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively
    Paavonen, K
    HorelliKuitunen, N
    Chilov, D
    Kukk, E
    Pennanen, S
    Kallioniemi, OP
    Pajusola, K
    Olofsson, B
    Eriksson, U
    Joukov, V
    Palotie, A
    Alitalo, K
    [J]. CIRCULATION, 1996, 93 (06) : 1079 - 1082
  • [27] Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors
    Saaristo, A
    Partanen, TA
    Arola, J
    Jussila, L
    Hytönen, M
    Mäkitie, A
    Vento, S
    Kaipainen, A
    Malmberg, H
    Alitalo, K
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (01) : 7 - 14
  • [28] Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes
    Saaristo, A
    Veikkola, T
    Enholm, B
    Hytönen, M
    Arola, J
    Pajusola, K
    Turunen, P
    Jeltsch, M
    Karkkainen, MJ
    Kerjaschki, D
    Bueler, H
    Ylä-Herttuala, S
    Alitalo, K
    [J]. FASEB JOURNAL, 2002, 16 (09) : 1041 - 1049
  • [29] Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation
    Saharinen, P
    Tammela, T
    Karkkainen, MJ
    Alitalo, K
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (07) : 387 - 395
  • [30] Sayegh Mazin E, 2004, Gastric Cancer, V7, P140